Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing Surveillance.

Wu, Haishan; Wang, Xijin; Liu, Xuejun; Sang, Hong; Bo, Qijing; Yang, Xiaodong; Xun, Zhiyuan; Li, Keqing; Zhang, Ruiling; Sun, Meijuan; Cai, Duanfang; Deng, Huaili; Zhao, Guijun; Li, Juhong; Liu, Xianglai; Zhan, Guilai; Chen, Jindong

Wu, Haishan; Wang, Xijin; Liu, Xuejun; Sang, Hong; Bo, Qijing; Yang, Xiaodong; Xun, Zhiyuan; Li, Keqing; Zhang, Ruiling; Sun, Meijuan; Cai, Duanfang; Deng, Huaili; Zhao, Guijun; Li, Juhong; Liu, Xianglai; Zhan, Guilai; Chen, Jindong.

Afiliação

Wu H; National Clinical Research Center for Mental Disorders, Department of Psychiatry, China National Technology Institute on Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.
Wang X; The First Psychiatric Hospital of Harbin, Harbin, China.
Liu X; Brain Hospital of Hunan Province, Changsha, China.
Sang H; Changchun Sixth Hospital, Changchun, China.
Bo Q; Beijing Anding Hospital, Capital Medical University, Beijing, China.
Yang X; Shandong Mental Health Center, Jinan, China.
Xun Z; Tianjin Anding Hospital, Tianjin, China.
Li K; Hebei Provincial Mental Health Center, Baoding, China.
Zhang R; Henan Mental Hospital, Xinxiang, China.
Sun M; Daqing Third Hospital, Daqing, China.
Cai D; The Fifth People's Hospital of Zigong, Zigong, China.
Deng H; Psychiatric Hospital of Taiyuan, Taiyuan, China.
Zhao G; Guangyuan Mental Health Center, Guangyuan, China.
Li J; The Fourth People's Hospital of Chengdu, Chengdu, China.
Liu X; Hainan Provincial Anning Hospital, Haikou, China.
Zhan G; Xuhui Mental Health Center, Shanghai, China.
Chen J; National Clinical Research Center for Mental Disorders, Department of Psychiatry, China National Technology Institute on Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.

Front Psychiatry ; 13: 935769, 2022.

Article em En | MEDLINE | ID: mdl-36061293

Palavras-chave

blonanserin; effectiveness; post-marketing surveillance; safety; schizophrenia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Psychiatry Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google